ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
30.30
-0.02 (-0.07%)
Sep 23, 2026, 1:33 PM EDT - Market open
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.49 billion as of September 23, 2026. Its market cap has increased by 97.78% in one year.
Market Cap
1.49B
Enterprise Value
1.12B
1-Year Change
97.78%
Ranking
Category
Stock Price
$30.30
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.49B, an increase of 159.73%. That is a compound annual growth rate of 43.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.49B | 79.88% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kardigan | 1.52B |
| Innoviva | 1.52B |
| Korsana Biosciences | 1.51B |
| Ascentage Pharma Group International | 1.49B |
| Bicara Therapeutics | 1.46B |
| Ultragenyx Pharmaceutical | 1.44B |
| Alpha Tau Medical | 1.43B |
| Damora Therapeutics | 1.41B |